Endosonographic examination of thyroid gland among patients with nonthyroid cancers.

Autor: Alkhatib AA; Southwestern Regional Medical Center, Cancer Treatment Centers of America, Tulsa, OK, USA; Department of Gastroenterology, Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE., Mahayni AA; Southwestern Regional Medical Center, Cancer Treatment Centers of America, Tulsa, OK, USA., Chawki GR; Southwestern Regional Medical Center, Cancer Treatment Centers of America, Tulsa, OK, USA., Yoder L; Southwestern Regional Medical Center, Cancer Treatment Centers of America, Tulsa, OK, USA., Elkhatib FA; Division of Endocrinology, INTEGRIS Southwest Medical Center, OKC, OK, USA., Al-Haddad M; Department of Gastroenterology, Digestive Disease Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.
Jazyk: angličtina
Zdroj: Endoscopic ultrasound [Endosc Ultrasound] 2016 Sep-Oct; Vol. 5 (5), pp. 328-334.
DOI: 10.4103/2303-9027.191664
Abstrakt: Objectives: There is limited endosonographic literature regarding thyroid gland pathology, which is frequently visualized during upper endoscopic ultrasound (EUS). Our objective was to assess the prevalence of benign and malignant thyroid lesions encountered during routine upper EUS within a cancer center setting.
Materials and Methods: The data were prospectively collected and retrospectively analyzed. All upper EUS procedures performed between October 2012 and July 2014 were reviewed at a large referral cancer center. Data collected included patient demographics, preexisting thyroid conditions, thyroid gland dimensions, the presence or absence of thyroid lesions, and EUS morphology of lesions if present, and interventions performed to characterize thyroid lesions and pathology results when applicable.
Results: Two hundred and forty-five EUS procedures were reviewed. Of these, 100 cases reported a detailed endosonographic examination of the thyroid gland. Most of the thyroid glands were endosonographically visualized when the tip of the scope was at 18 cm from the incisors. Twelve cases showed thyroid lesions, out of which three previously undiagnosed thyroid cancers were visualized during EUS (two primary papillary thyroid cancers and one anaplastic thyroid cancer). Transesophageal EUS-guided fine needle aspiration of thyroid lesions was feasible when the lesion was in the inferior portion of the thyroid gland, and the tip of the scope was at 18 cm or more from the incisors.
Conclusions: Routine EUS examination may detect unexpected thyroid lesions including malignant ones. We encourage endosonographers to screen the visualized portions of the thyroid gland during routine withdrawal of the echoendoscope.
Databáze: MEDLINE
načítá se...